Xenotransplantation and Risk: Regulating a Developing Biotechnology
Price comparison
Enter a valid email at checkout. Your ebook download link is sent to the email address you provide — double-check it before completing your order.
30-day money-back guarantee. File issue? We replace it or refund you — no questions asked.
Digital product — no physical item will be shipped
You'll receive a PDF download link by email immediately after checkout.
Can't find the ebook you're looking for?
Send us the book cover image via the live chat on our website and we'll request it for you. Estimated response time: 10 minutes.
Book details
- Format
- PDF — instant download
- Language
- English
About this book
Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health.
About the Author
Sara Fovargue is a Senior Lecturer in Law at Lancaster University, where she specialises in health care law and ethics. Her main interests are clinical research involving human and non-human animals, risk and regulation with regards to developing biotechnologies and decision-making practices for vulnerable groups within health care law and practice.
| Author | Sara Fovargue |
| ISBN-13 | 9781139209106 |
| Publisher | Cambridge University Press |
| Publication Date | 11/17/2011 |
| Series | Cambridge Law, Medicine and Ethics |
Why buy from us
- 100% Authorised by publisher — licensed copy, never pirated
- –84% Less than Amazon Kindle — lowest price guaranteed
- Instant PDF delivered the moment your payment clears, 24/7
- Full Complete edition — every chapter, no missing pages